• SENSEX 73,055.43
    -193.96 (--0.26%)
  • BANKNIFTY 54,925.70
    -51.20 (--0.09%)
  • SBI
    950.75 900.80(%)
  • Cyient
    1,268.00 1,226.25(%)
  • NSE
    1,640.25 1,683.00(%)
  • JSW Energy
    440.25 428.00(%)
  • Voltas
    940.00 970.70(%)
  • Eternal
    317.50 344.75(%)
  • IndusInd Bank
    832.00 750.45(%)
  • Persistent Systems
    5,909.85 6,597.00(%)
  • Swiggy
    174.90 207.75(%)
  • Cupid
    302.45 45.40(%)
  • TCS
    2,624.75 3,336.70(%)
  • Infosys
    1,198.30 1,727.85(%)
  • Havells India
    1,003.65 1,015.20(%)
  • C P C L
    1,529.95 1,677.00(%)
  • Lenskart Solut.
    615.80 355.70(%)
  • Divi's Lab.
    8,800.00 5,648.00(%)
  • PC Jeweller
    17.08 7.45(%)
  • Steel Str. Wheel
    469.70 434.05(%)
  • Reliance Industries
    1,201.95 1,611.20(%)
  • Netweb Technol.
    4,238.00 2,942.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Shukra Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4083.0
  • ISIN : INE551C01044
62.53 -6 (-8.53%)
  • As on 23 Oct 2026 (EOD)

  • Today’s Low

    62.05

  • Today’s High

    67.77

  • Open

    67.01

  • Perv Close

    68.36

  • 52W Low

    40.06

  • 52W High

    75.40

Key Indicators

  • P/E(TTM)

    77.15

  • Mar.Cap (₹Cr.)

    2,767.09

  • Div & Yield %

    0.02

  • Book Value(₹)

    2.28

  • Debt-Equity Ratio

    -8.53

  • AGM Date

    22-Oct-2026

  • EPS

    0.81

  • P/E Ratio

    77.15

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    2,767.09

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    44.25

  • BV (₹)

    2.30

  • Sales( ₹ in Cr.)

    56.71

  • NP (in Cr.)

    22.05

  • NP Var(%)

    130.0

  • Div%

    1.0

  • CPS (₹)

    0.60

  • EPS (₹)

    0.50

  • Traded Value (₹ in Lakhs)

    2,765.32

  • 52 Week High

    75.40

  • 52 Week Low

    40.06

  • Price BSE

    62.0

  • Price NSE

    63.00

  • Market Capital( in Cr.)

    2,765.32

  • P/C Ratio

    107.60

  • P/E Ratio

    124.40

  • Price Vs.BV

    0.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 56.71 32.59 74.57 58.83 20.49 11.20
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 56.71 32.59 74.57 58.83 20.49 11.20
Other Income 4.58 4.21 2.82 1.20 0.08 0.36
Stock Adjustments 3.60 3.63 -0.70 0.33 0.73 0.19
Total Income 64.89 40.43 76.69 60.36 21.30 11.75
EXPENDITURE :            
Raw Materials 19.45 11.75 43.78 45.65 11.08 2.96
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 1.78
Employee Cost 6.40 5.47 5.02 4.41 4.57 3.75
Other Manufacturing Expenses 0.19 0.18 0.05 0.11 0.17 0.09
Selling and Administration Expenses 4.96 5.83 5.15 3.38 2.44 1.36
Miscellaneous Expenses 0.53 0.27 0.47 0.26 0.07 0.21
Employee Benefit Expenses 6.40 5.47 5.02 4.41 4.57 3.75
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 31.52 23.50 54.46 53.80 18.33 10.14
Operating Profit 33.37 16.93 22.22 6.56 2.97 1.60
Interest 1.15 0.59 0.29 0.28 0.29 0.03
Gross Profit 32.22 16.34 21.93 6.28 2.68 1.57
Depreciation 3.44 3.00 2.05 1.84 1.66 1.47
Profit Before Tax 28.78 13.34 19.88 4.44 1.02 0.10
Current Tax 8.94 3.62 1.36 0.01 0.21 -0.20
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -2.22 0.14 -0.02 0.03 0.06 0.11
Reported Net Profit 22.05 9.58 18.54 4.41 0.75 0.19
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 -0.07
Adjusted Net Profit 22.05 9.58 18.54 4.41 0.75 0.26
Adjustment below Net Profit 0.00 -32.84 -0.01 0.00 0.00 0.00
P & L Balance brought forward 14.30 37.57 19.10 14.78 14.03 13.85
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.44 0.00 0.07 0.08 0.00 0.00
P & L Balance carried down 35.91 14.30 37.57 19.11 14.78 14.03
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1.00 1.00 10.00 5.00 5.00 0.00
Dividend Per Share(Rs) 0.01 0.01 1.00 0.50 0.50 0.00
Earnings Per Share-Unit Curr 0.50 0.22 16.93 11.26 4.79 1.20
Earnings Per Share(Adj)-Unit Curr 0.50 0.22 0.42 0.28 0.02 0.01
Book Value 1.93 1.44 52.65 64.63 104.43 99.63
Book Value(Adj)-Unit Curr 1.93 1.44 1.32 1.61 0.54 0.51

Shareholding Pattern

  • Promoter Group

    51.15%

  • Public Share Holding

    48.85%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 210,250,600 47.83 210,250,600 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 14,620,000 3.33 14,620,000 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 224,870,600 51.15 224,870,600 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 500,000 0.11 500,000 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 15,000 0.00 15,000 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 515,000 0.12 515,000 2
2] Non Institution
Bodies Corporate 693,841 0.16 693,831 41
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 168,360,852 38.30 168,360,852 130
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10,936,361 2.49 10,936,361 21
Individuals holding nominal share capital up to Rs. 1 lakh 30,120,745 6.85 29,337,075 27,930
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 4,117,041 0.94 4,029,361 253
Sub Total 214,228,840 48.73 213,357,480 28,375
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 439,614,440 100.00 438,743,080 28,384

Company Background

Shukra Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Shukra Pharmaceuticals Ltd
  • BSE Code : 4083.0
  • ISIN : INE551C01044

  • Incorporation Year

    1993

  • Registered Office

    3 rd Floor Dev House
    Opp WIAA Office Judges Bungalo, Ahmedabad,
    Gujarat-380054

  • Telephone

    91-079-66522247/27498515

  • FAX

  • Chairman

    Dakshesh Shah

  • Managing Director

    Dakshesh Shah

  • Company Secretary

    Shivkant Dhakad

  • Auditor

    MAAK & Associates

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Shukra Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Shukra Pharma. 62.49 61.29 56.71 77.15 36.93
Abbott India 25,393.50 7,217.19 6,929.05 33.42 43.78
Astrazeneca Phar 6,098.65 2,304.07 2,275.58 89.88 27.86
Glaxosmi. Pharma 2,434.70 3,932.76 3,790.20 38.89 58.17
Novartis India 1,686.70 393.10 354.33 42.59 15.94
Cipla 1,329.90 20,102.60 18,979.95 34.95 13.88
Bliss GVS Pharma 640.25 773.53 729.81 59.50 12.51
Amrutanjan Healt 495.80 520.13 502.55 26.56 24.16
Fermenta Biotec. 457.40 474.15 450.25 21.35 18.77
Guj. Themis Bio. 355.10 168.25 165.82 94.95 18.05
Ambalal Sarabhai 36.28 19.52 3.94 67.19 6.77